Broad-Spectrum Clearance of Lipopolysaccharides from Blood Based on Hemocompatible Dihistidine Polymer
Time:2023-06-16 09:04 Author:Junjun Chen
Junjun Chen, Zhenqiang Shi,* Xijing Yang, Xiaoyu Zhang, Dongdong Wang, Shengxu Qian, Wenjing Sun, Cunli Wang, Qiongya Li, Zhengjian Wang, Yanling,* and Guangyan Qing*
ACS Appl. Mater. Interfaces 2023, DOI: 10.1021/acsami.3c05341
https://doi.org/10.1021/acsami.3c05341
Blood infection can release toxic bacterial lipopolysaccharides (LPSs) into bloodstream, trigger a series of inflammatory reactions, and eventually lead to multiple organ dysfunction, irreversible shock and even death, which seriously threatens human life and health. Herein, a functional block copolymer with excellent hemocompatibility is proposed to enable broad-spectrum clearance of LPS from whole blood blindly before pathogen identification, facilitating timely rescue from sepsis. A dipeptide ligand of histidine-histidine (HH) was designed as the LPS binding unit, and poly[(trimethylamine N-oxide)-co-(histidine-histidine)], a functional block copolymer combining the LPS ligand of HH and a zwitterionic antifouling unit of trimethylamine N-oxide (TMAO), was then designed by reversible addition-fragmentation chain transfer (RAFT) polymerization. The functional polymer achieved effective clearance of LPSs from solutions and whole blood in a broad-spectrum manner, and had good antifouling, anti-interference properties and hemocompatibility. The proposed functional dihistidine polymer provides a novel strategy for achieving broad-spectrum clearance of LPSs, with potential applications in clinical blood purification.